All stock lists
Itron, Inc. (NASDAQ:ITRI)
US · Delayed Price · Currency is USD
Technology · Hardware, Equipment & Parts
87.47-0.18 (-0.21%)
Insider Score
––Not scored
ITRI Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ITRI analyst forecast
ITRI analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
ITRI 12-month price target
No published price targets in the last 12 months.
Best analysts covering ITRI
- Stephens & Co.100%success rate · 1 call
- TD Cowen75%success rate · 4 calls
- Baird75%success rate · 4 calls
- Oppenheimer60%success rate · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ITRI analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Needham | Buy | — | — | Reiterated | 2026-07-29 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2026-05-20 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-04-29 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-04-16 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-04-16 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-02-18 |
| — | Baird | Outperform | — | — | Upgraded | 2026-02-18 |
| — | Guggenheim | Neutral | — | — | Downgraded | 2026-02-17 |
| — | Guggenheim | Neutral | — | — | Downgraded | 2026-02-13 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-01-27 |
| — | Johnson Rice | Buy | — | — | Reiterated | 2026-01-05 |
| — | Argus Research | Hold | — | — | Downgraded | 2025-11-04 |
| — | Baird | Neutral | — | — | Downgraded | 2025-10-31 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-10-16 |
| — | Stephens & Co. | Equal Weight | — | — | Reiterated | 2025-10-07 |
| — | JP Morgan | Overweight | — | — | Upgraded | 2025-07-31 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-07-22 |
| — | Roth Capital | Buy | — | — | Reiterated | 2025-07-22 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-07-14 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2025-05-05 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-04-17 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-02-27 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2025-02-27 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-02-26 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-02-26 |
| — | Guggenheim | Buy | — | — | Reiterated | 2024-11-06 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2024-11-01 |
| — | TD Cowen | Buy | — | — | Reiterated | 2024-11-01 |
| — | Baird | Outperform | — | — | Reiterated | 2024-11-01 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-11-01 |
| — | Roth MKM | Buy | — | — | Reiterated | 2024-11-01 |
| — | Roth MKM | Buy | — | — | Reiterated | 2024-08-21 |
| — | Stephens & Co. | Equal Weight | — | — | Reiterated | 2024-08-05 |
| — | Roth MKM | Buy | — | — | Reiterated | 2024-08-02 |
| — | Baird | Outperform | — | — | Reiterated | 2024-08-02 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2024-07-22 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-07-17 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-07-16 |
| — | Roth MKM | Buy | — | — | Reiterated | 2024-07-16 |
| — | Guggenheim | Buy | — | — | Upgraded | 2024-07-11 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-06-20 |
| — | Piper Sandler | Neutral | — | — | Downgraded | 2024-05-21 |
| — | Stephens & Co. | Equal Weight | — | — | Reiterated | 2024-05-06 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-05-03 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-05-03 |
| — | TD Cowen | Buy | — | — | Reiterated | 2024-05-03 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-05-03 |
| — | Roth MKM | Buy | — | — | Reiterated | 2024-05-03 |
| — | Roth MKM | Buy | — | — | Reiterated | 2024-04-23 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-04-11 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-03-13 |
| — | Baird | Outperform | — | — | Reiterated | 2024-03-13 |
| — | TD Cowen | Outperform | — | — | Reiterated | 2024-03-13 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-02-27 |
| — | Baird | Outperform | — | — | Upgraded | 2024-02-27 |
| — | Oppenheimer | Outperform | — | — | Upgraded | 2024-01-19 |
| — | Raymond James | Market Perform | — | — | Downgraded | 2024-01-04 |
| — | Piper Sandler | Overweight | — | — | Upgraded | 2023-12-19 |
| — | JP Morgan | Neutral | — | — | Upgraded | 2023-12-12 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2023-11-03 |
ITRI earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-17 | 2.19 | 2.46 | $561.5M | $571.7M |
| 2026-04-28 | 1.26 | 1.49 | $572.0M | $587.0M |
| 2026-07-28 | 1.29 | 1.59 | $566.3M | $562.9M |
| 2026-10-27 | 1.56 | 0.00 | $595.5M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.